T1	CHEM 64 74	ticagrelor
#1	AnnotatorNotes T1	C1999375; ticagrelor; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T2	CHEM 77 88	clopidogrel
#2	AnnotatorNotes T2	C0070166; clopidogrel; Organic Chemical · Pharmacologic Substance
T3	DISO 106 123	diabetes mellitus
#3	AnnotatorNotes T3	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T4	DISO 126 158	enfermedad isquémica del corazón
#4	AnnotatorNotes T4	C0151744; Myocardial Ischemia; Disease or Syndrome
T5	CHEM 199 209	Ticagrelor
#5	AnnotatorNotes T5	C1999375; ticagrelor; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T6	CHEM 212 223	Clopidogrel
#6	AnnotatorNotes T6	C0070166; clopidogrel; Organic Chemical · Pharmacologic Substance
T7	DISO 241 262	cardiopatía isquémica
#7	AnnotatorNotes T7	C0151744; Myocardial Ischemia; Disease or Syndrome
T8	DISO 266 290	Diabetes Mellitus tipo 2
#8	AnnotatorNotes T8	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T9	DISO 297 299	DM
#9	AnnotatorNotes T9	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T10	PROC 305 341	estudio farmacodinámico aleatorizado
T11	ANAT 387 406	arterias coronarias
#10	AnnotatorNotes T11	C0205042; Coronary artery; Body Part, Organ, or Organ Component + C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T12	CHEM 443 450	oxígeno
#11	AnnotatorNotes T12	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T13	ANAT 454 461	corazón
#12	AnnotatorNotes T13	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T14	DISO 474 488	dolor torácico
#13	AnnotatorNotes T14	C0008031; Chest Pain; Sign or Symptom
T15	DISO 491 498	infarto
#14	AnnotatorNotes T15	C0021308; Infarction; Pathologic Function | C0027051; Myocardial infarction; Disease or Syndrome | C0155626; Acute myocardial infarction; Disease or Syndrome
T16	DISO 525 554	Enfermedad arterial coronaria
T17	ANAT 545 554	coronaria
#15	AnnotatorNotes T17	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T18	PROC 646 657	tratamiento
#16	AnnotatorNotes T18	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T19	DISO 729 753	Diabetes mellitus tipo 2
#17	AnnotatorNotes T19	C0011860; Diabetes Mellitus, Non-Insulin-Dependent; Disease or Syndrome
T20	DISO 795 816	Cardiopatía isquémica
#18	AnnotatorNotes T20	C0151744; Myocardial Ischemia; Disease or Syndrome
T21	DISO 424 450	falta de aporte de oxígeno
#19	AnnotatorNotes T21	C0003130; Anoxia; Pathologic Function
T22	PROC 832 843	angiografía
#20	AnnotatorNotes T22	C0002978; angiogram; Diagnostic Procedure
T23	PROC 848 867	Tratamiento crónico
#21	AnnotatorNotes T23	C0023977; Long-term care; Health Care Activity (?)
T24	CHEM 881 889	aspirina
#22	AnnotatorNotes T24	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T25	DISO 932 940	Alergias
#23	AnnotatorNotes T25	C1527304; Allergic Reaction; Pathologic Function
T26	CHEM 953 964	clopidogrel
#24	AnnotatorNotes T26	C0070166; clopidogrel; Organic Chemical · Pharmacologic Substance
T27	CHEM 967 977	ticagrelor
#25	AnnotatorNotes T27	C1999375; ticagrelor; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T28	DISO 982 1003	Discrasias sanguíneas
#26	AnnotatorNotes T28	C0018939; Hematological Disease; Disease or Syndrome
T29	DISO 1018 1042	síndrome coronario agudo
#27	AnnotatorNotes T29	C0948089; Acute Coronary Syndrome; Disease or Syndrome
T30	DISO 1065 1091	inestabilidad hemodinámica
#28	AnnotatorNotes T30	C0948268; Hemodynamic instability; Disease or Syndrome
T31	PROC 1096 1121	Tratamiento antiplaquetar
#29	AnnotatorNotes T31	C1096021; Antiplatelet therapy; Therapeutic or Preventive Procedure
T32	CHEM 1163 1171	aspirina
#30	AnnotatorNotes T32	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T33	CHEM 1185 1199	tienopiridinas
T34	CHEM 1201 1211	cilostazol
#31	AnnotatorNotes T34	C0055729; cilostazol; Organic Chemical · Pharmacologic Substance
T35	CHEM 1213 1224	dipiridamol
#32	AnnotatorNotes T35	C0012582; dipyridamole; Organic Chemical · Pharmacologic Substance
T36	CHEM 1226 1266	inhibidores de la glicoproteína IIb/IIIa
T37	PROC 660 673	procedimiento
#33	AnnotatorNotes T37	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T38	PROC 1579 1605	fórmula de Cockcroft-Gault
#34	AnnotatorNotes T38	C2711451; Estimation of creatinine clearance by Cockcroft-Gault formula; Laboratory Procedure
T39	CHEM 1298 1317	derivado cumarínico
#35	AnnotatorNotes T39	C1629021; Long-acting coumarin derivative; Pharmacologic Substance (?)
T40	DISO 1322 1332	Hemorragia
#36	AnnotatorNotes T40	C0019080; Hemorrhage; Pathologic Function
T41	PROC 1477 1495	Recuento plaquetar
T42	DISO 1365 1370	ictus
#37	AnnotatorNotes T42	C0038454; Cerebrovascular accident; Disease or Syndrome
T43	DISO 1372 1403	accidente isquémico transitorio
#38	AnnotatorNotes T43	C0007787; Transient Ischemic Attack; Disease or Syndrome
T44	DISO 1406 1429	hemorragia intracraneal
#39	AnnotatorNotes T44	C0151699; Intracranial Hemorrhage; Pathologic Function
T45	DISO 1516 1535	Insuficiencia renal
#40	AnnotatorNotes T45	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T46	PROC 1558 1577	filtrado glomerular
#41	AnnotatorNotes T46	C0017654; Glomerular Filtration Rate; Diagnostic Procedure
T47	DISO 1622 1631	Neoplasia
#42	AnnotatorNotes T47	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C1882062; Neoplastic disease; Neoplastic Process
T48	ANAT 151 158	corazón
#43	AnnotatorNotes T48	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T49	DISO 365 406	Estrechamiento de las arterias coronarias
T50	ANAT 480 488	torácico
#44	AnnotatorNotes T50	C0817096; Chest; Body Location or Region | C1269614; Entire thorax; Body Part, Organ, or Organ Component
T51	ANAT 536 544	arterial
#45	AnnotatorNotes T51	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T52	CHEM 943 951	aspirina
#46	AnnotatorNotes T52	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T53	ANAT 993 1003	sanguíneas
#47	AnnotatorNotes T53	C0005767; Blood; Body Substance
T54	ANAT 1027 1036	coronario
#48	AnnotatorNotes T54	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T55	ANAT 1417 1429	intracraneal
#49	AnnotatorNotes T55	C0524466; Intracranial; Body Location or Region
T56	ANAT 1530 1535	renal
#50	AnnotatorNotes T56	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T57	PROC 1644 1647	ALT
#51	AnnotatorNotes T57	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T58	PROC 594 618	consentimiento informado
#52	AnnotatorNotes T58	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T59	PROC 1270 1290	Anticoagulación oral
#53	AnnotatorNotes T59	C0003281; Anticoagulation Therapy; Therapeutic or Preventive Procedure + C0001563; Administration, Oral; Therapeutic or Preventive Procedure | C1273553; Oral administration of treatment; Therapeutic or Preventive Procedure
T60	Date 13 17	2014
T61	LIVB 92 101	pacientes
#54	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	LIVB 227 236	pacientes
#55	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T63	Spec_cue 411 416	puede
T64	Age 706 724	entre 18 y 75 años
T65	Duration 860 867	crónico
#56	AnnotatorNotes T65	C0205191; chronic; Temporal Concept
T66	Duration 869 875	>1 mes
T67	Dose 891 896	100mg
T68	Frequency 896 900	/día
T69	Date 1043 1051	reciente
T70	Duration 1053 1061	<30 días
T71	PHYS 1079 1091	hemodinámica
#57	AnnotatorNotes T71	C0019010; Hemodynamics; Organ or Tissue Function
T72	Date 1122 1130	reciente
T73	Duration 1132 1140	<14 días
T74	Route 1286 1290	oral
#58	AnnotatorNotes T74	C1527415; Oral Route of Drug administration; Functional Concept
T75	Date 1353 1361	reciente
T76	Duration 1392 1403	transitorio
#59	AnnotatorNotes T76	C0205374; Transitory; Temporal Concept
T77	Duration 1431 1439	<6 meses
T79	PHYS 1714 1723	Gestación
#60	AnnotatorNotes T79	C0032961; Pregnancy; Organism Function
T80	Neg_cue 1143 1162	con la excepción de
T78	PHYS 313 328	farmacodinámico
#61	AnnotatorNotes T78	C0851347; Pharmacodynamics; Biologic Function
T81	ANAT 1486 1495	plaquetar
#62	AnnotatorNotes T81	C0005821; Blood platelets; Cell
T82	ANAT 1567 1577	glomerular
#63	AnnotatorNotes T82	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
A1	Assertion T21 Speculated
A2	Assertion T32 Negated
A3	Status T42 History_of
A4	Status T43 History_of
A5	Status T44 History_of
#64	AnnotatorNotes T10	C1709518; Pharmacodynamic Study; Research Activity + C0034656; Randomization; Research Activity
#65	AnnotatorNotes T16	C1956346; Coronary Artery Disease; Disease or Syndrome
#66	AnnotatorNotes T33	C1120149; thienopyridine; Organic Chemical · Pharmacologic Substance
#67	AnnotatorNotes T41	C0032181; Platelet Count measurement; Laboratory Procedure
R1	Experiences Arg1:T61 Arg2:T2	
R2	Experiences Arg1:T61 Arg2:T1	
R3	Experiences Arg1:T61 Arg2:T3	
R4	Experiences Arg1:T61 Arg2:T4	
R5	Location_of Arg1:T48 Arg2:T4	
R6	Overlap Arg1:T3 Arg2:T4	
R7	Overlap Arg1:T7 Arg2:T8	
R8	Overlap Arg1:T7 Arg2:T9	
R9	Experiences Arg1:T62 Arg2:T7	
R10	Experiences Arg1:T62 Arg2:T8	
R11	Experiences Arg1:T62 Arg2:T9	
R12	Experiences Arg1:T62 Arg2:T6	
R13	Experiences Arg1:T62 Arg2:T5	
R14	Location_of Arg1:T11 Arg2:T49	
R15	Speculation Arg1:T63 Arg2:T21	
R16	Location_of Arg1:T13 Arg2:T21	
R17	Causes Arg1:T49 Arg2:T21	
R20	Location_of Arg1:T50 Arg2:T14	
R21	Location_of Arg1:T13 Arg2:T15	
R22	Location_of Arg1:T17 Arg2:T16	
R23	Before Arg1:T58 Arg2:T18	
R24	Before Arg1:T58 Arg2:T37	
R25	Has_Duration_or_Interval Arg1:T23 Arg2:T65	
R27	Used_for Arg1:T24 Arg2:T23	
R28	Has_Dose_or_Strength Arg1:T24 Arg2:T67	
R29	Has_Frequency Arg1:T24 Arg2:T68	
R26	Has_Duration_or_Interval Arg1:T24 Arg2:T66	
R30	Causes Arg1:T52 Arg2:T25	
R31	Causes Arg1:T26 Arg2:T25	
R32	Causes Arg1:T27 Arg2:T25	
R33	Location_of Arg1:T53 Arg2:T28	
A6	Status T25 History_of
R34	Location_of Arg1:T54 Arg2:T29	
R35	Overlap Arg1:T29 Arg2:T69	
R36	Overlap Arg1:T29 Arg2:T70	
R37	Overlap Arg1:T31 Arg2:T72	
R39	Negation Arg1:T80 Arg2:T32	
R40	Used_for Arg1:T33 Arg2:T31	
R41	Used_for Arg1:T34 Arg2:T31	
R42	Used_for Arg1:T35 Arg2:T31	
R43	Used_for Arg1:T36 Arg2:T31	
R45	Has_Route_or_Mode Arg1:T39 Arg2:T74	
R46	Used_for Arg1:T39 Arg2:T59	
R38	Has_Duration_or_Interval Arg1:T34 Arg2:T73	
R44	Has_Duration_or_Interval Arg1:T35 Arg2:T73	
R47	Has_Duration_or_Interval Arg1:T36 Arg2:T73	
R48	Overlap Arg1:T42 Arg2:T75	
R49	Overlap Arg1:T43 Arg2:T75	
R50	Has_Duration_or_Interval Arg1:T43 Arg2:T76	
R51	Location_of Arg1:T55 Arg2:T44	
R52	Overlap Arg1:T44 Arg2:T77	
R53	Overlap Arg1:T43 Arg2:T77	
R54	Overlap Arg1:T42 Arg2:T77	
T83	CONC 1451 1471	período de inclusión
R55	Before Arg1:T44 Arg2:T83	
R56	Before Arg1:T43 Arg2:T83	
R57	Before Arg1:T42 Arg2:T83	
T84	Quantifier_or_Qualifier 1536 1542	severa
R58	Location_of Arg1:T56 Arg2:T45	
R59	Has_Quantifier_or_Qualifier Arg1:T45 Arg2:T84	
R60	Location_of Arg1:T82 Arg2:T46	
R62	Overlap Arg1:T44 Arg2:T75	
T86	Result_or_Value 1496 1511	<100x106/microl
R63	Has_Result_or_Value Arg1:T41 Arg2:T86	
T87	Result_or_Value 1607 1616	<30mL/min
R64	Has_Result_or_Value Arg1:T46 Arg2:T87	
T88	Result_or_Value 1648 1708	basal superior a 2,5 veces el límite normal de la normalidad
R65	Has_Result_or_Value Arg1:T57 Arg2:T88	
R66	Experiences Arg1:T62 Arg2:T78	
R68	Used_for Arg1:T32 Arg2:T31	
R19	Causes Arg1:T49 Arg2:T14	
R18	Causes Arg1:T49 Arg2:T15	
R69	Location_of Arg1:T51 Arg2:T16	
T90	Quantifier_or_Qualifier 1333 1339	activa
R70	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T90	
T91	Quantifier_or_Qualifier 1632 1638	activa
R71	Has_Quantifier_or_Qualifier Arg1:T47 Arg2:T91	
#69	AnnotatorNotes T69	C0332185; Recent; Temporal Concept
#70	AnnotatorNotes T72	C0332185; Recent; Temporal Concept
#71	AnnotatorNotes T75	C0332185; Recent; Temporal Concept
#68	AnnotatorNotes T90	C0679217; Active State; Idea or Concept
#72	AnnotatorNotes T84	C1547227; Severe - Severity of Illness Code; Intellectual Product
#73	AnnotatorNotes T91	C0679217; Active State; Idea or Concept
#74	AnnotatorNotes T36	C3640054; Glycoprotein IIb/IIIa Antagonist; Chemical Viewed Functionally
#75	AnnotatorNotes T49	C0242231; Coronary Stenosis; Disease or Syndrome
A7	Experiencer T62 Patient
A8	Experiencer T61 Patient
